Stadium Capital Management’s CRH Medical Corporation CRHM Stock Holding History

Stadium Capital Management’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-624,291	Closed	-$1.35M	–	13
2020 Q3	$1.35M	Sell	624,291 -1,311,877	-68%	-$3.06M	0.64%	13
2020 Q2	$4.01M	Sell	1,936,168 -1,595,622	-45%	-$3.22M	1.61%	10
2020 Q1	$4.73M	Sell	3,531,790 -1,340,535	-28%	-$4.38M	2.68%	9
2019 Q4	$16.9M	Sell	4,872,325 -116,506	-2%	-$368K	22.84%	2
2019 Q3	$15.4M	Buy	4,988,831 +730,880	+17%	+$2.17M	9.24%	3
2019 Q2	$12.9M	Buy	4,257,951 +598,591	+16%	+$1.71M	5.96%	4
2019 Q1	$9.73M	Buy	3,659,360 +1,476,877	+68%	+$4.56M	5.17%	7
2018 Q4	$6.66M	Buy	2,182,483 +1,619,527	+288%	+$5.34M	2.76%	10
2018 Q3	$2.22M	Sell	562,956 -695,327	-55%	-$2.56M	0.85%	11
2018 Q2	$3.9M	Sell	1,258,283 -398,485	-24%	-$1.27M	1.58%	10
2018 Q1	$4.22M	Buy	1,656,768 +546,614	+49%	+$1.53M	1.89%	11
2017 Q4	$2.94M	Buy	+1,110,154	New	+$2.48M	1.6%	7

Other funds holding CRHM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stadium Capital Management's CRHM Position: Q4 2020 in Review

Stadium Capital Management sold out of CRH Medical Corporation (CRHM) in Q4 2020, closing a stake of 624,291 shares — an estimated $1.35M sold.

Stadium Capital Management first reported a position in CRHM in Q4 2017 and held it in 12 quarters. The position peaked at $16.9M in Q4 2019. 37 funds tracked by Wall St. Rank hold CRHM as of Q4 2020.

Stadium Capital Management reported no remaining CRH Medical Corporation position as of Q4 2020 after selling out during the quarter.
Stadium Capital Management sold 624,291 CRH Medical Corporation shares in Q4 2020, an estimated $1.35M.
Stadium Capital Management first reported a position in CRH Medical Corporation in Q4 2017 and held it in 12 quarters.
Stadium Capital Management's CRH Medical Corporation position peaked at $16.9M in Q4 2019.
37 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q4 2020.

Based on Stadium Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.